By SIMON CONSTABLE
Giant pharmaceutical company Eli Lilly reported better-than-expected first-quarter earnings and said it expects full-year earnings to grow by up to 5%, but still investors were disappointed sending the stock lower in premarket trading. Read more here.
Giant pharmaceutical company Eli Lilly reported better-than-expected first-quarter earnings and said it expects full-year earnings to grow by up to 5%, but still investors were disappointed sending the stock lower in premarket trading. Read more here.